

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.26370121 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.26370121 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.94491755 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.94491755 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.40755997 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.96561209 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.79926338 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.68348555 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.68348555 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.68348555 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.66525268 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.66164855 |
| 13 | urea metabolic process (GO:0019627) | 5.54867477 |
| 14 | urea cycle (GO:0000050) | 5.54867477 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 5.49374110 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.36689116 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.35707202 |
| 18 | cysteine metabolic process (GO:0006534) | 5.28111302 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.25517407 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.18495464 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.15028900 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.11623689 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 5.10864109 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.09806973 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.03891820 |
| 26 | protein carboxylation (GO:0018214) | 5.03891820 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.92305690 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89378400 |
| 29 | bile acid metabolic process (GO:0008206) | 4.85667074 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.82586904 |
| 31 | regulation of complement activation (GO:0030449) | 4.80472252 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.79365432 |
| 33 | lysine metabolic process (GO:0006553) | 4.73853320 |
| 34 | lysine catabolic process (GO:0006554) | 4.73853320 |
| 35 | L-serine metabolic process (GO:0006563) | 4.71007455 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.61664673 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.60728802 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.56062584 |
| 39 | * alpha-amino acid catabolic process (GO:1901606) | 4.55957000 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.55286153 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.50922397 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.50922397 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.49653456 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.49653456 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.49653456 |
| 46 | negative regulation of sterol transport (GO:0032372) | 4.39296827 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.39296827 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 4.39217976 |
| 49 | coenzyme catabolic process (GO:0009109) | 4.36423513 |
| 50 | glycine metabolic process (GO:0006544) | 4.31581909 |
| 51 | plasma lipoprotein particle clearance (GO:0034381) | 4.30501475 |
| 52 | * cellular amino acid catabolic process (GO:0009063) | 4.27912916 |
| 53 | cellular modified amino acid catabolic process (GO:0042219) | 4.22960585 |
| 54 | glutamate metabolic process (GO:0006536) | 4.21597168 |
| 55 | ethanol oxidation (GO:0006069) | 4.16605715 |
| 56 | serine family amino acid metabolic process (GO:0009069) | 4.15989504 |
| 57 | phospholipid efflux (GO:0033700) | 4.15093663 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 4.14719029 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.05437145 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 4.04366478 |
| 61 | cellular glucuronidation (GO:0052695) | 3.99589049 |
| 62 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99503322 |
| 63 | indolalkylamine metabolic process (GO:0006586) | 3.97578321 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 3.93937414 |
| 65 | serine family amino acid biosynthetic process (GO:0009070) | 3.93661013 |
| 66 | intestinal cholesterol absorption (GO:0030299) | 3.91616078 |
| 67 | cholesterol efflux (GO:0033344) | 3.91208588 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 3.88057372 |
| 69 | amine catabolic process (GO:0009310) | 3.88057372 |
| 70 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.86734364 |
| 71 | positive regulation of lipid catabolic process (GO:0050996) | 3.84282262 |
| 72 | short-chain fatty acid metabolic process (GO:0046459) | 3.83816328 |
| 73 | proline metabolic process (GO:0006560) | 3.83476047 |
| 74 | arginine metabolic process (GO:0006525) | 3.79084503 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 3.78926218 |
| 76 | * organic acid catabolic process (GO:0016054) | 3.75408200 |
| 77 | * carboxylic acid catabolic process (GO:0046395) | 3.75408200 |
| 78 | drug catabolic process (GO:0042737) | 3.73265211 |
| 79 | phospholipid homeostasis (GO:0055091) | 3.72397025 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 3.70942378 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.67654007 |
| 82 | cytolysis (GO:0019835) | 3.67169202 |
| 83 | fibrinolysis (GO:0042730) | 3.65460970 |
| 84 | negative regulation of lipase activity (GO:0060192) | 3.64670466 |
| 85 | valine metabolic process (GO:0006573) | 3.63674879 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 3.63219806 |
| 87 | aspartate family amino acid catabolic process (GO:0009068) | 3.60964177 |
| 88 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.60717896 |
| 89 | regulation of bile acid biosynthetic process (GO:0070857) | 3.59450218 |
| 90 | ketone body metabolic process (GO:1902224) | 3.58375210 |
| 91 | protein-lipid complex assembly (GO:0065005) | 3.55626258 |
| 92 | fatty acid beta-oxidation (GO:0006635) | 3.55113228 |
| 93 | cholesterol homeostasis (GO:0042632) | 3.54489450 |
| 94 | fatty acid oxidation (GO:0019395) | 3.54394669 |
| 95 | complement activation (GO:0006956) | 3.54338263 |
| 96 | complement activation, classical pathway (GO:0006958) | 3.53859268 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51839335 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51703499 |
| 99 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51703499 |
| 100 | monocarboxylic acid catabolic process (GO:0072329) | 3.51686878 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.49491317 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.49491317 |
| 103 | sterol homeostasis (GO:0055092) | 3.49376713 |
| 104 | cofactor catabolic process (GO:0051187) | 3.48943335 |
| 105 | lipid oxidation (GO:0034440) | 3.48095504 |
| 106 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.39587794 |
| 107 | proline biosynthetic process (GO:0006561) | 3.34592835 |
| 108 | fatty acid homeostasis (GO:0055089) | 3.28707445 |
| 109 | regulation of plasminogen activation (GO:0010755) | 3.27861135 |
| 110 | biotin metabolic process (GO:0006768) | 3.24065286 |
| 111 | blood coagulation, intrinsic pathway (GO:0007597) | 3.20736374 |
| 112 | plasma lipoprotein particle organization (GO:0071827) | 3.14747663 |
| 113 | protein-lipid complex subunit organization (GO:0071825) | 3.07926351 |
| 114 | creatine metabolic process (GO:0006600) | 3.06278116 |
| 115 | regulation of apoptotic cell clearance (GO:2000425) | 3.04917811 |
| 116 | gluconeogenesis (GO:0006094) | 2.96211812 |
| 117 | 4-hydroxyproline metabolic process (GO:0019471) | 2.93618062 |
| 118 | oxaloacetate metabolic process (GO:0006107) | 2.89303474 |
| 119 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.88777537 |
| 120 | acylglycerol catabolic process (GO:0046464) | 2.88494421 |
| 121 | neutral lipid catabolic process (GO:0046461) | 2.88494421 |
| 122 | lung epithelium development (GO:0060428) | 2.88153673 |
| 123 | hexose biosynthetic process (GO:0019319) | 2.87249816 |
| 124 | NADH metabolic process (GO:0006734) | 2.85689549 |
| 125 | low-density lipoprotein particle clearance (GO:0034383) | 2.84507292 |
| 126 | diacylglycerol metabolic process (GO:0046339) | 2.78928389 |
| 127 | glycogen catabolic process (GO:0005980) | 2.72287154 |
| 128 | response to muscle activity (GO:0014850) | 2.66376731 |
| 129 | regulation of cholesterol metabolic process (GO:0090181) | 2.61179969 |
| 130 | monosaccharide biosynthetic process (GO:0046364) | 2.60767614 |
| 131 | ethanol metabolic process (GO:0006067) | 2.59048998 |
| 132 | response to mercury ion (GO:0046689) | 2.57254602 |
| 133 | muscle filament sliding (GO:0030049) | 2.54463249 |
| 134 | actin-myosin filament sliding (GO:0033275) | 2.54463249 |
| 135 | triglyceride catabolic process (GO:0019433) | 2.53101453 |
| 136 | positive regulation of synapse maturation (GO:0090129) | 2.51055961 |
| 137 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.48928938 |
| 138 | central nervous system myelination (GO:0022010) | 2.47064280 |
| 139 | axon ensheathment in central nervous system (GO:0032291) | 2.47064280 |
| 140 | glutamine family amino acid catabolic process (GO:0009065) | 2.43765168 |
| 141 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.43497723 |
| 142 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.39847184 |
| 143 | glucan catabolic process (GO:0009251) | 2.39048101 |
| 144 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.38544909 |
| 145 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.37907445 |
| 146 | exogenous drug catabolic process (GO:0042738) | 2.34947760 |
| 147 | negative regulation of lipid transport (GO:0032369) | 2.33541112 |
| 148 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.31949899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.94599868 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.81547430 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.27517433 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.19002534 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.74531177 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.08334837 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.54403205 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.10200892 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51878951 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.49540407 |
| 11 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.29212653 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17232775 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12576060 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09037134 |
| 15 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.02398529 |
| 16 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.01797082 |
| 17 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2728093 |
| 18 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.87428267 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.87181331 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.83277393 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75082490 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74461919 |
| 23 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.61883188 |
| 24 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.60889544 |
| 25 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.57108437 |
| 26 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54543077 |
| 27 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.50181392 |
| 28 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.47214826 |
| 29 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45262916 |
| 30 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41223550 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40848604 |
| 32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39157769 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34976189 |
| 34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32551294 |
| 35 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32245413 |
| 36 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30048157 |
| 37 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.28159948 |
| 38 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.26576693 |
| 39 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24961645 |
| 40 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20941590 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.20713351 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.20713351 |
| 43 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20388790 |
| 44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19854961 |
| 45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18990959 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18209089 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17895214 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16806183 |
| 49 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.16509897 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15747280 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12427956 |
| 52 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.11919076 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11665409 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10186179 |
| 55 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.08105915 |
| 56 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07674640 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.07278209 |
| 58 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06750550 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06431422 |
| 60 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05915233 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05577331 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.03702311 |
| 63 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02806541 |
| 64 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.01531058 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01363620 |
| 66 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.99903842 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97210101 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96424928 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95561120 |
| 70 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.95150527 |
| 71 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95137507 |
| 72 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95063132 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95005429 |
| 74 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.94550003 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93559115 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93096199 |
| 77 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.90965599 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90849235 |
| 79 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90770661 |
| 80 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90214673 |
| 81 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89842354 |
| 82 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.89198226 |
| 83 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88880293 |
| 84 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.87718141 |
| 85 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.86557407 |
| 86 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.86551430 |
| 87 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86322081 |
| 88 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85244189 |
| 89 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85040769 |
| 90 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.84636095 |
| 91 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84070503 |
| 92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83954487 |
| 93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.83947880 |
| 94 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.83725414 |
| 95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83361722 |
| 96 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82919156 |
| 97 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.82080844 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81789312 |
| 99 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.81232071 |
| 100 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81103292 |
| 101 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81000938 |
| 102 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80812977 |
| 103 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.80435284 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79974091 |
| 105 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.79594963 |
| 106 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73674563 |
| 107 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73674563 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70464755 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68765201 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68362644 |
| 111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67560795 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66067033 |
| 113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65991807 |
| 114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.62293959 |
| 115 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61756423 |
| 116 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60318838 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.60056262 |
| 118 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.58384655 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.56646186 |
| 120 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.56522082 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56210051 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55942093 |
| 123 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.54654790 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.54551069 |
| 125 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53621234 |
| 126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.52904142 |
| 127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.51161833 |
| 128 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.50816031 |
| 129 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.50094906 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.49928786 |
| 131 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.49146868 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48249213 |
| 133 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.48151285 |
| 134 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47491307 |
| 135 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.46675604 |
| 136 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.46196025 |
| 137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46040255 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45867446 |
| 139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45691318 |
| 140 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.45542615 |
| 141 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.45542615 |
| 142 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.44898903 |
| 143 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.44844923 |
| 144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44748112 |
| 145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44485943 |
| 146 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.44210003 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.43823329 |
| 148 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.43732701 |
| 149 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.43639012 |
| 150 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.43444670 |
| 151 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43429663 |
| 152 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.43263959 |
| 153 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.43219065 |
| 154 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.42997092 |
| 155 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.42847577 |
| 156 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.41294718 |
| 157 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.41099983 |
| 158 | AR_20517297_ChIP-Seq_VCAP_Human | 0.40745201 |
| 159 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.38814971 |
| 160 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.38540981 |
| 161 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.38128648 |
| 162 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38031846 |
| 163 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.37933384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.14176696 |
| 2 | MP0005360_urolithiasis | 7.16975343 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.22608674 |
| 4 | MP0005365_abnormal_bile_salt | 6.14838666 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.87328811 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.07864470 |
| 7 | MP0003252_abnormal_bile_duct | 3.85346276 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.67273525 |
| 9 | MP0000566_synostosis | 3.41076099 |
| 10 | MP0009840_abnormal_foam_cell | 2.98917033 |
| 11 | MP0005083_abnormal_biliary_tract | 2.91636617 |
| 12 | MP0003122_maternal_imprinting | 2.88242988 |
| 13 | MP0005332_abnormal_amino_acid | 2.83567570 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.59821103 |
| 15 | MP0003195_calcinosis | 2.48422402 |
| 16 | MP0000751_myopathy | 2.28159346 |
| 17 | MP0003123_paternal_imprinting | 2.25387722 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.22101075 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.20445301 |
| 20 | MP0000609_abnormal_liver_physiology | 2.15767528 |
| 21 | MP0003646_muscle_fatigue | 2.06555469 |
| 22 | MP0004270_analgesia | 1.98585968 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.97782863 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 1.92782003 |
| 25 | MP0003868_abnormal_feces_composition | 1.92050304 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.83460918 |
| 27 | MP0004233_abnormal_muscle_weight | 1.71139490 |
| 28 | MP0005670_abnormal_white_adipose | 1.69305774 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.66022758 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.62664414 |
| 31 | MP0002089_abnormal_postnatal_growth/wei | 1.60703737 |
| 32 | MP0000749_muscle_degeneration | 1.56785990 |
| 33 | MP0004130_abnormal_muscle_cell | 1.55165297 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54132945 |
| 35 | MP0001764_abnormal_homeostasis | 1.52282299 |
| 36 | MP0004087_abnormal_muscle_fiber | 1.51530605 |
| 37 | MP0010030_abnormal_orbit_morphology | 1.47717569 |
| 38 | MP0004858_abnormal_nervous_system | 1.46405451 |
| 39 | MP0002249_abnormal_larynx_morphology | 1.44118239 |
| 40 | MP0005647_abnormal_sex_gland | 1.40463790 |
| 41 | MP0002106_abnormal_muscle_physiology | 1.33076494 |
| 42 | MP0005451_abnormal_body_composition | 1.30060087 |
| 43 | MP0003011_delayed_dark_adaptation | 1.23411341 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.22513237 |
| 45 | MP0003186_abnormal_redox_activity | 1.21783679 |
| 46 | MP0003942_abnormal_urinary_system | 1.20802188 |
| 47 | MP0003941_abnormal_skin_development | 1.20174244 |
| 48 | MP0004859_abnormal_synaptic_plasticity | 1.19994972 |
| 49 | MP0005369_muscle_phenotype | 1.19391537 |
| 50 | MP0009697_abnormal_copulation | 1.17369980 |
| 51 | MP0003890_abnormal_embryonic-extraembry | 1.16606224 |
| 52 | MP0002697_abnormal_eye_size | 1.15794898 |
| 53 | MP0000759_abnormal_skeletal_muscle | 1.15601262 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.13421241 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.13296791 |
| 56 | MP0003121_genomic_imprinting | 1.13139274 |
| 57 | MP0000598_abnormal_liver_morphology | 1.11564596 |
| 58 | MP0000762_abnormal_tongue_morphology | 1.10579078 |
| 59 | MP0003136_yellow_coat_color | 1.07279625 |
| 60 | MP0001299_abnormal_eye_distance/ | 1.05378467 |
| 61 | MP0010630_abnormal_cardiac_muscle | 1.05170095 |
| 62 | MP0005423_abnormal_somatic_nervous | 1.04586264 |
| 63 | MP0002254_reproductive_system_inflammat | 1.04340101 |
| 64 | MP0002971_abnormal_brown_adipose | 1.03530029 |
| 65 | MP0004036_abnormal_muscle_relaxation | 1.00323855 |
| 66 | MP0001346_abnormal_lacrimal_gland | 0.99786170 |
| 67 | MP0000604_amyloidosis | 0.99029065 |
| 68 | MP0003315_abnormal_perineum_morphology | 0.97764349 |
| 69 | MP0005076_abnormal_cell_differentiation | 0.97193496 |
| 70 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97143178 |
| 71 | MP0006292_abnormal_olfactory_placode | 0.97140696 |
| 72 | MP0003119_abnormal_digestive_system | 0.96915985 |
| 73 | MP0009764_decreased_sensitivity_to | 0.96218059 |
| 74 | MP0005330_cardiomyopathy | 0.96071041 |
| 75 | MP0002876_abnormal_thyroid_physiology | 0.95412867 |
| 76 | MP0003879_abnormal_hair_cell | 0.94345175 |
| 77 | MP0006138_congestive_heart_failure | 0.93805990 |
| 78 | MP0004272_abnormal_basement_membrane | 0.93302503 |
| 79 | MP0005409_darkened_coat_color | 0.93249757 |
| 80 | MP0005334_abnormal_fat_pad | 0.92823683 |
| 81 | MP0000003_abnormal_adipose_tissue | 0.90556146 |
| 82 | MP0003115_abnormal_respiratory_system | 0.89658636 |
| 83 | MP0003690_abnormal_glial_cell | 0.89361883 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.89253740 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 0.89035688 |
| 86 | MP0010234_abnormal_vibrissa_follicle | 0.88920211 |
| 87 | MP0001661_extended_life_span | 0.88713991 |
| 88 | MP0002108_abnormal_muscle_morphology | 0.87809353 |
| 89 | MP0004133_heterotaxia | 0.87737541 |
| 90 | MP0009763_increased_sensitivity_to | 0.87144385 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 0.85053938 |
| 92 | MP0000534_abnormal_ureter_morphology | 0.84561588 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.83617464 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 0.82817466 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.82704051 |
| 96 | MP0000955_abnormal_spinal_cord | 0.81422114 |
| 97 | MP0000537_abnormal_urethra_morphology | 0.81057071 |
| 98 | MP0001915_intracranial_hemorrhage | 0.80238523 |
| 99 | MP0003861_abnormal_nervous_system | 0.80233280 |
| 100 | MP0000778_abnormal_nervous_system | 0.79998908 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.79630166 |
| 102 | MP0002233_abnormal_nose_morphology | 0.77672758 |
| 103 | MP0001529_abnormal_vocalization | 0.77314163 |
| 104 | MP0005535_abnormal_body_temperature | 0.77124088 |
| 105 | MP0005257_abnormal_intraocular_pressure | 0.76893215 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.76446722 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.75775473 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.74059735 |
| 109 | MP0005620_abnormal_muscle_contractility | 0.73796480 |
| 110 | MP0003329_amyloid_beta_deposits | 0.72511538 |
| 111 | MP0001730_embryonic_growth_arrest | 0.71723622 |
| 112 | MP0001984_abnormal_olfaction | 0.70693606 |
| 113 | MP0002092_abnormal_eye_morphology | 0.70581719 |
| 114 | MP0001756_abnormal_urination | 0.70439281 |
| 115 | MP0001293_anophthalmia | 0.69820900 |
| 116 | MP0004197_abnormal_fetal_growth/weight/ | 0.69515575 |
| 117 | MP0003878_abnormal_ear_physiology | 0.68455554 |
| 118 | MP0005377_hearing/vestibular/ear_phenot | 0.68455554 |
| 119 | MP0009703_decreased_birth_body | 0.68439074 |
| 120 | MP0001286_abnormal_eye_development | 0.68349999 |
| 121 | MP0002938_white_spotting | 0.68070855 |
| 122 | MP0005266_abnormal_metabolism | 0.67931026 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.67858107 |
| 124 | MP0000733_abnormal_muscle_development | 0.67415486 |
| 125 | MP0000750_abnormal_muscle_regeneration | 0.66328931 |
| 126 | MP0009053_abnormal_anal_canal | 0.65107796 |
| 127 | MP0003938_abnormal_ear_development | 0.65046221 |
| 128 | MP0002234_abnormal_pharynx_morphology | 0.64608158 |
| 129 | MP0005408_hypopigmentation | 0.64486926 |
| 130 | MP0005448_abnormal_energy_balance | 0.64131059 |
| 131 | MP0008469_abnormal_protein_level | 0.63168690 |
| 132 | MP0010368_abnormal_lymphatic_system | 0.61694453 |
| 133 | MP0005248_abnormal_Harderian_gland | 0.58798371 |
| 134 | MP0009384_cardiac_valve_regurgitation | 0.58254245 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.58075805 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.56980276 |
| 137 | MP0009115_abnormal_fat_cell | 0.54959439 |
| 138 | MP0006035_abnormal_mitochondrial_morpho | 0.54037049 |
| 139 | MP0002796_impaired_skin_barrier | 0.53458382 |
| 140 | MP0000639_abnormal_adrenal_gland | 0.52894697 |
| 141 | MP0002269_muscular_atrophy | 0.52497139 |
| 142 | MP0005395_other_phenotype | 0.48998971 |
| 143 | MP0009672_abnormal_birth_weight | 0.47200219 |
| 144 | MP0003953_abnormal_hormone_level | 0.47058977 |
| 145 | MP0002970_abnormal_white_adipose | 0.45808886 |
| 146 | MP0001881_abnormal_mammary_gland | 0.45619032 |
| 147 | MP0002822_catalepsy | 0.42051580 |
| 148 | MP0008874_decreased_physiological_sensi | 0.41707850 |
| 149 | MP0003959_abnormal_lean_body | 0.41180393 |
| 150 | MP0000579_abnormal_nail_morphology | 0.40994811 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.40366563 |
| 152 | MP0003718_maternal_effect | 0.39557491 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.38681791 |
| 154 | MP0002168_other_aberrant_phenotype | 0.38639088 |
| 155 | MP0003075_altered_response_to | 0.38463607 |
| 156 | MP0000427_abnormal_hair_cycle | 0.37804327 |
| 157 | MP0002060_abnormal_skin_morphology | 0.36665965 |
| 158 | MP0004043_abnormal_pH_regulation | 0.36344179 |
| 159 | MP0005166_decreased_susceptibility_to | 0.34244401 |
| 160 | MP0002928_abnormal_bile_duct | 0.34134294 |
| 161 | MP0000230_abnormal_systemic_arterial | 0.33076431 |
| 162 | MP0005187_abnormal_penis_morphology | 0.31782712 |
| 163 | MP0009780_abnormal_chondrocyte_physiolo | 0.31221594 |
| 164 | MP0008873_increased_physiological_sensi | 0.30894266 |
| 165 | MP0000747_muscle_weakness | 0.30741701 |
| 166 | MP0003300_gastrointestinal_ulcer | 0.30450446 |
| 167 | MP0002090_abnormal_vision | 0.29764610 |
| 168 | MP0008872_abnormal_physiological_respon | 0.29549348 |
| 169 | MP0005452_abnormal_adipose_tissue | 0.28712766 |
| 170 | MP0008438_abnormal_cutaneous_collagen | 0.28026416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.14027870 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.01353011 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.94589753 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.48630048 |
| 5 | Xanthomatosis (HP:0000991) | 6.18629286 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.09777364 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.02745154 |
| 8 | Complement deficiency (HP:0004431) | 5.50017490 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.46005511 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.81206115 |
| 11 | Hyperglycinemia (HP:0002154) | 4.79310254 |
| 12 | Hyperammonemia (HP:0001987) | 4.73201501 |
| 13 | Epidermoid cyst (HP:0200040) | 4.62627199 |
| 14 | Nemaline bodies (HP:0003798) | 4.60093985 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 4.57434264 |
| 16 | Ketosis (HP:0001946) | 4.51194073 |
| 17 | Hyperglycinuria (HP:0003108) | 4.50994086 |
| 18 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.44828795 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.44144858 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.44144858 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.43300625 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.41933897 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.22774656 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22196608 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.19548258 |
| 26 | Joint hemorrhage (HP:0005261) | 4.17161919 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 4.07024866 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.97668096 |
| 29 | Exercise-induced myalgia (HP:0003738) | 3.94921320 |
| 30 | Abnormality of complement system (HP:0005339) | 3.93206312 |
| 31 | Fat malabsorption (HP:0002630) | 3.91656557 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.75098446 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71642340 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.61410156 |
| 35 | Exercise-induced muscle cramps (HP:0003710) | 3.59230749 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.51653011 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.46010013 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.41017153 |
| 39 | Type 1 muscle fiber predominance (HP:0003803) | 3.39855815 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.33134093 |
| 41 | Ketoacidosis (HP:0001993) | 3.27428874 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.20093759 |
| 43 | Myopathic facies (HP:0002058) | 3.14605301 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05531129 |
| 45 | Hyperbilirubinemia (HP:0002904) | 2.99969912 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.98789929 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.96168978 |
| 48 | Myocardial infarction (HP:0001658) | 2.95081766 |
| 49 | Steatorrhea (HP:0002570) | 2.93894281 |
| 50 | Skin nodule (HP:0200036) | 2.88093600 |
| 51 | Spastic diplegia (HP:0001264) | 2.85973415 |
| 52 | Spontaneous abortion (HP:0005268) | 2.78718362 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.77591616 |
| 54 | Metabolic acidosis (HP:0001942) | 2.66687412 |
| 55 | Hepatoblastoma (HP:0002884) | 2.62277232 |
| 56 | Calcaneovalgus deformity (HP:0001848) | 2.61016738 |
| 57 | Gout (HP:0001997) | 2.59016958 |
| 58 | Hypochromic microcytic anemia (HP:0004840) | 2.57888013 |
| 59 | Bronchomalacia (HP:0002780) | 2.57195746 |
| 60 | Lethargy (HP:0001254) | 2.55296385 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.47198299 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.47198299 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.45790139 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.45075785 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.45059617 |
| 66 | Cholelithiasis (HP:0001081) | 2.43386096 |
| 67 | Abnormality of glycolysis (HP:0004366) | 2.42908593 |
| 68 | Distal arthrogryposis (HP:0005684) | 2.42158840 |
| 69 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.41936943 |
| 70 | Increased serum pyruvate (HP:0003542) | 2.39174544 |
| 71 | Neonatal onset (HP:0003623) | 2.38731847 |
| 72 | Vascular calcification (HP:0004934) | 2.38629668 |
| 73 | Hypoglycemic seizures (HP:0002173) | 2.37551598 |
| 74 | Cholecystitis (HP:0001082) | 2.32868505 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.32868505 |
| 76 | Cerebral edema (HP:0002181) | 2.31080217 |
| 77 | Acanthocytosis (HP:0001927) | 2.28349243 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.26522250 |
| 79 | Irritability (HP:0000737) | 2.24101404 |
| 80 | Deformed tarsal bones (HP:0008119) | 2.22306311 |
| 81 | Malnutrition (HP:0004395) | 2.21038880 |
| 82 | Pancreatitis (HP:0001733) | 2.17560676 |
| 83 | Mitral stenosis (HP:0001718) | 2.16293900 |
| 84 | Brushfield spots (HP:0001088) | 2.15595695 |
| 85 | Pterygium (HP:0001059) | 2.15495029 |
| 86 | Cardiovascular calcification (HP:0011915) | 2.15356679 |
| 87 | Round ear (HP:0100830) | 2.15351687 |
| 88 | Amyloidosis (HP:0011034) | 2.15168681 |
| 89 | Small epiphyses (HP:0010585) | 2.13527316 |
| 90 | Esophageal varix (HP:0002040) | 2.12772280 |
| 91 | Bifid scrotum (HP:0000048) | 2.12415825 |
| 92 | Aplasia involving bones of the extremities (HP:0009825) | 2.11693748 |
| 93 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.11693748 |
| 94 | Aplasia of the phalanges of the hand (HP:0009802) | 2.11693748 |
| 95 | Choanal stenosis (HP:0000452) | 2.11596179 |
| 96 | Calf muscle hypertrophy (HP:0008981) | 2.09999794 |
| 97 | Hemorrhage of the eye (HP:0011885) | 2.08976152 |
| 98 | Hydroxyprolinuria (HP:0003080) | 2.08920553 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 2.08920553 |
| 100 | Late onset (HP:0003584) | 2.06752516 |
| 101 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.03719407 |
| 102 | Glomerulonephritis (HP:0000099) | 2.03281697 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 2.02204622 |
| 104 | Hyperglycemia (HP:0003074) | 2.01310668 |
| 105 | Enlarged kidneys (HP:0000105) | 1.99451025 |
| 106 | Vomiting (HP:0002013) | 1.98693220 |
| 107 | Abnormality of the gallbladder (HP:0005264) | 1.97594037 |
| 108 | Abnormality of the calcaneus (HP:0008364) | 1.96879641 |
| 109 | Myoglobinuria (HP:0002913) | 1.96066577 |
| 110 | Vaginal fistula (HP:0004320) | 1.95028513 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94855552 |
| 112 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93089395 |
| 113 | EMG: myopathic abnormalities (HP:0003458) | 1.92678816 |
| 114 | Difficulty running (HP:0009046) | 1.92577650 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92388108 |
| 116 | Back pain (HP:0003418) | 1.92382768 |
| 117 | Status epilepticus (HP:0002133) | 1.90575856 |
| 118 | Muscle stiffness (HP:0003552) | 1.90492011 |
| 119 | Abnormality of the Achilles tendon (HP:0005109) | 1.90416167 |
| 120 | Hypertriglyceridemia (HP:0002155) | 1.89204361 |
| 121 | Rimmed vacuoles (HP:0003805) | 1.88280230 |
| 122 | Hyperuricemia (HP:0002149) | 1.87037222 |
| 123 | Increased purine levels (HP:0004368) | 1.87037222 |
| 124 | Renal duplication (HP:0000075) | 1.86210020 |
| 125 | Opisthotonus (HP:0002179) | 1.83200340 |
| 126 | Ulnar deviation of the wrist (HP:0003049) | 1.83094748 |
| 127 | Rickets (HP:0002748) | 1.81744677 |
| 128 | Turricephaly (HP:0000262) | 1.80323629 |
| 129 | Renovascular hypertension (HP:0100817) | 1.80217894 |
| 130 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.77875412 |
| 131 | Partial duplication of thumb phalanx (HP:0009944) | 1.77771309 |
| 132 | Broad alveolar ridges (HP:0000187) | 1.77204823 |
| 133 | Hypophosphatemic rickets (HP:0004912) | 1.76474626 |
| 134 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76318894 |
| 135 | Thrombophlebitis (HP:0004418) | 1.75762623 |
| 136 | Generalized aminoaciduria (HP:0002909) | 1.75116031 |
| 137 | Coronal craniosynostosis (HP:0004440) | 1.75039815 |
| 138 | Menorrhagia (HP:0000132) | 1.74541379 |
| 139 | Hyperacusis (HP:0010780) | 1.73065926 |
| 140 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.71227357 |
| 141 | Ulnar bowing (HP:0003031) | 1.71093140 |
| 142 | Poikilocytosis (HP:0004447) | 1.70927702 |
| 143 | Neck muscle weakness (HP:0000467) | 1.69519096 |
| 144 | Gingival bleeding (HP:0000225) | 1.69492891 |
| 145 | Abnormality of carpal bone ossification (HP:0006257) | 1.68676302 |
| 146 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.67486752 |
| 147 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.65142042 |
| 148 | Subaortic stenosis (HP:0001682) | 1.65142042 |
| 149 | Hyporeflexia of lower limbs (HP:0002600) | 1.64494816 |
| 150 | Malignant hyperthermia (HP:0002047) | 1.61954474 |
| 151 | Shallow orbits (HP:0000586) | 1.59629325 |
| 152 | Neonatal short-limb short stature (HP:0008921) | 1.58116263 |
| 153 | Adducted thumb (HP:0001181) | 1.55196646 |
| 154 | Transposition of the great arteries (HP:0001669) | 1.53221962 |
| 155 | Abnormal connection of the cardiac segments (HP:0011545) | 1.53221962 |
| 156 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.53221962 |
| 157 | Abnormality of the calf musculature (HP:0001430) | 1.52908516 |
| 158 | Protrusio acetabuli (HP:0003179) | 1.52726738 |
| 159 | Alacrima (HP:0000522) | 1.51564508 |
| 160 | Achilles tendon contracture (HP:0001771) | 1.50487631 |
| 161 | Myotonia (HP:0002486) | 1.50229627 |
| 162 | Stridor (HP:0010307) | 1.50083125 |
| 163 | Increased variability in muscle fiber diameter (HP:0003557) | 1.49774140 |
| 164 | Trigonocephaly (HP:0000243) | 1.49583485 |
| 165 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.49552655 |
| 166 | Absent epiphyses (HP:0010577) | 1.49552655 |
| 167 | Increased nuchal translucency (HP:0010880) | 1.47447826 |
| 168 | Abnormality of pain sensation (HP:0010832) | 1.46625576 |
| 169 | Impaired pain sensation (HP:0007328) | 1.46625576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.67980356 |
| 2 | SIK1 | 4.75379371 |
| 3 | ERN1 | 3.95026290 |
| 4 | FGFR4 | 3.28078268 |
| 5 | TRIB3 | 2.89038859 |
| 6 | ERBB4 | 2.73709322 |
| 7 | LATS1 | 2.69584348 |
| 8 | INSRR | 2.56940072 |
| 9 | MAP2K4 | 2.30539244 |
| 10 | PKN2 | 2.21652870 |
| 11 | TAOK3 | 2.19240365 |
| 12 | CDK12 | 2.01410293 |
| 13 | FRK | 1.96701504 |
| 14 | MST1R | 1.91136060 |
| 15 | WNK4 | 1.87955439 |
| 16 | CAMK1D | 1.75489407 |
| 17 | SMG1 | 1.75331479 |
| 18 | MARK1 | 1.68485265 |
| 19 | FGFR2 | 1.68103643 |
| 20 | MAPK11 | 1.63818076 |
| 21 | PIK3CG | 1.63309948 |
| 22 | PTK6 | 1.61763474 |
| 23 | PRKD3 | 1.51204720 |
| 24 | MAP3K9 | 1.49987795 |
| 25 | PINK1 | 1.45260398 |
| 26 | STK38L | 1.43219719 |
| 27 | DAPK2 | 1.36553051 |
| 28 | PRKAA2 | 1.31938713 |
| 29 | MAP3K7 | 1.28778560 |
| 30 | NTRK2 | 1.24714899 |
| 31 | CAMK1G | 1.22015322 |
| 32 | PDK4 | 1.21187984 |
| 33 | PDK3 | 1.21187984 |
| 34 | NEK1 | 1.19892648 |
| 35 | LATS2 | 1.15575956 |
| 36 | MET | 1.15278687 |
| 37 | FLT3 | 1.14384477 |
| 38 | EPHA2 | 1.13752335 |
| 39 | NTRK3 | 1.12022844 |
| 40 | NEK9 | 1.11228893 |
| 41 | ICK | 1.07533291 |
| 42 | AKT3 | 1.05161785 |
| 43 | PDGFRA | 1.04791199 |
| 44 | RIPK1 | 1.03007752 |
| 45 | PHKG1 | 1.02392139 |
| 46 | PHKG2 | 1.02392139 |
| 47 | CDK6 | 1.01274794 |
| 48 | JAK2 | 1.01142459 |
| 49 | ERBB2 | 1.00882776 |
| 50 | ABL2 | 0.96327041 |
| 51 | PRKAA1 | 0.91498633 |
| 52 | PDK2 | 0.81576019 |
| 53 | PIK3CA | 0.81051854 |
| 54 | MAPK12 | 0.79825366 |
| 55 | ARAF | 0.79334215 |
| 56 | MAP2K3 | 0.78402589 |
| 57 | CDC7 | 0.78147743 |
| 58 | TTN | 0.77298197 |
| 59 | FER | 0.76512741 |
| 60 | CSNK1E | 0.76347344 |
| 61 | PRKCZ | 0.75689655 |
| 62 | CAMK2G | 0.71602178 |
| 63 | JAK1 | 0.70631496 |
| 64 | RET | 0.70178810 |
| 65 | OBSCN | 0.69670433 |
| 66 | WNK1 | 0.69123704 |
| 67 | GSK3A | 0.67388993 |
| 68 | RPS6KB1 | 0.66848634 |
| 69 | MTOR | 0.66818048 |
| 70 | TYK2 | 0.66775254 |
| 71 | EEF2K | 0.66377512 |
| 72 | EPHB1 | 0.65658161 |
| 73 | MARK2 | 0.65275571 |
| 74 | CDK7 | 0.65153810 |
| 75 | KSR2 | 0.63812834 |
| 76 | PRKACG | 0.62993039 |
| 77 | EPHA4 | 0.62696947 |
| 78 | BMX | 0.62600097 |
| 79 | NME1 | 0.62509999 |
| 80 | PDPK1 | 0.62398997 |
| 81 | SGK3 | 0.62351739 |
| 82 | STK38 | 0.61199148 |
| 83 | MAPK10 | 0.60649762 |
| 84 | FGFR3 | 0.60214389 |
| 85 | PNCK | 0.60005005 |
| 86 | MAP3K3 | 0.59749092 |
| 87 | MAP2K1 | 0.59557238 |
| 88 | DYRK2 | 0.58468196 |
| 89 | SGK1 | 0.57348866 |
| 90 | PTK2 | 0.57252982 |
| 91 | CASK | 0.56799271 |
| 92 | BRSK1 | 0.55957184 |
| 93 | RPS6KB2 | 0.54680830 |
| 94 | UHMK1 | 0.54634565 |
| 95 | TTK | 0.54381548 |
| 96 | DMPK | 0.52718646 |
| 97 | LMTK2 | 0.51552327 |
| 98 | CAMK1 | 0.51548284 |
| 99 | MAP3K10 | 0.50570049 |
| 100 | CAMK2B | 0.49477154 |
| 101 | RPS6KA3 | 0.49356118 |
| 102 | MAPK4 | 0.49318036 |
| 103 | CSNK1G1 | 0.49191861 |
| 104 | NEK2 | 0.48296941 |
| 105 | MAP3K2 | 0.47920755 |
| 106 | CDK11A | 0.47817545 |
| 107 | CDK15 | 0.46716738 |
| 108 | GSK3B | 0.46683639 |
| 109 | STK39 | 0.46488343 |
| 110 | DYRK1B | 0.46059215 |
| 111 | MAPKAPK3 | 0.45295853 |
| 112 | PKN1 | 0.44860209 |
| 113 | CDK1 | 0.44043604 |
| 114 | CAMK4 | 0.43924313 |
| 115 | RPS6KA1 | 0.43536638 |
| 116 | MAP3K4 | 0.43470537 |
| 117 | PAK3 | 0.42783315 |
| 118 | CAMK2D | 0.41969589 |
| 119 | ALK | 0.41576941 |
| 120 | SIK2 | 0.41487049 |
| 121 | TYRO3 | 0.40474616 |
| 122 | CDK18 | 0.40019265 |
| 123 | CDK5 | 0.39563860 |
| 124 | CDK2 | 0.39343001 |
| 125 | MAP3K11 | 0.39303501 |
| 126 | MAPK7 | 0.39207707 |
| 127 | PRKDC | 0.38980215 |
| 128 | DDR2 | 0.38951504 |
| 129 | IGF1R | 0.38896508 |
| 130 | PAK2 | 0.38735714 |
| 131 | FGFR1 | 0.38154595 |
| 132 | BRAF | 0.38100647 |
| 133 | PDK1 | 0.37796207 |
| 134 | CSNK1G2 | 0.37544561 |
| 135 | SGK2 | 0.35600615 |
| 136 | MAP2K6 | 0.35576054 |
| 137 | MAPK14 | 0.35559173 |
| 138 | CSNK1D | 0.35510519 |
| 139 | SGK223 | 0.35260713 |
| 140 | SGK494 | 0.35260713 |
| 141 | STK3 | 0.34176858 |
| 142 | EPHA3 | 0.33866142 |
| 143 | MAP3K6 | 0.33594285 |
| 144 | CSK | 0.32445692 |
| 145 | TAOK2 | 0.30588591 |
| 146 | NTRK1 | 0.30448835 |
| 147 | MAP3K5 | 0.29177716 |
| 148 | PRKCG | 0.28479892 |
| 149 | AKT2 | 0.27677104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.34005280 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.92912836 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40582141 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15353654 |
| 5 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96485305 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68060527 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66358405 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59919200 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59640287 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.58970037 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55341659 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55204695 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.26167694 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16197703 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10389206 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07922748 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.03206197 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00504623 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95885047 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76128381 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75571957 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73966480 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73714040 |
| 24 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73481788 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70389979 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70352462 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63350491 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.54569285 |
| 29 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54202786 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53256890 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53004789 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52950644 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51145263 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50833787 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.47673669 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46968729 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37895721 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37563164 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32942104 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32249866 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30406270 |
| 42 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27453337 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25538410 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24880822 |
| 45 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.21986716 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.13880045 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08616465 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.07776894 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02703278 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02628689 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02330332 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02045791 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01274044 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93744325 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88833991 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.88090062 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87598787 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80355940 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77158417 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76883125 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.76211350 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75489653 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71376991 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71227420 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68654226 |
| 66 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68493849 |
| 67 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62561418 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57589344 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56821449 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55096106 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54509607 |
| 72 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53481303 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51958476 |
| 74 | Tight junction_Homo sapiens_hsa04530 | 0.45418263 |
| 75 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44243379 |
| 76 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42010008 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.41750158 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41228049 |
| 79 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.40857326 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.39351335 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.35709829 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35393914 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35110401 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34618417 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33913724 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.32465290 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31963049 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31428892 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30181540 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29774288 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28276544 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27465711 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27302573 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25572935 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22779105 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22200228 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.21556590 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20827941 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19055427 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17420264 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.11454829 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.06261587 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2143695 |
| 104 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.2143415 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.2099003 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2012577 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | -0.1933724 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1803334 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1695925 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1623786 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | -0.1551694 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | -0.1372350 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1159624 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1069773 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0962019 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0902645 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0809530 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0709933 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0548126 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0267848 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0089216 |

